Clinical trial
A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
NCT00123318 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00123318 |
|---|---|
| Title | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer |
| Official title | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | The Royal Australian and New Zealand College of Radiologists |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug, Radiation |
| Interventions | epirubicin, cisplatin, 5-fluorouracil, Radiotherapy |
| Enrollment | 52 |
| Start date | Feb 1, 2003 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Jul 22, 2005 |
| Last update posted | Jun 18, 2013 |
| Countries | Australia, New Zealand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: